RU2002111414A - Substituted pyridines and pyridazines with the ability to inhibit angiogenesis - Google Patents
Substituted pyridines and pyridazines with the ability to inhibit angiogenesisInfo
- Publication number
- RU2002111414A RU2002111414A RU2002111414/04A RU2002111414A RU2002111414A RU 2002111414 A RU2002111414 A RU 2002111414A RU 2002111414/04 A RU2002111414/04 A RU 2002111414/04A RU 2002111414 A RU2002111414 A RU 2002111414A RU 2002111414 A RU2002111414 A RU 2002111414A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- substituted
- optionally substituted
- amino
- group
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title claims 4
- 150000004892 pyridazines Chemical class 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 70
- 125000003282 alkyl amino group Chemical class 0.000 claims 36
- 229910052760 oxygen Inorganic materials 0.000 claims 33
- 229910052717 sulfur Inorganic materials 0.000 claims 33
- 125000003277 amino group Chemical group 0.000 claims 25
- 125000000623 heterocyclic group Chemical group 0.000 claims 24
- 125000004429 atoms Chemical group 0.000 claims 23
- 229910052757 nitrogen Inorganic materials 0.000 claims 23
- 125000001072 heteroaryl group Chemical group 0.000 claims 21
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 18
- 125000001589 carboacyl group Chemical group 0.000 claims 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 15
- 125000003107 substituted aryl group Chemical group 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 12
- 125000004432 carbon atoms Chemical group C* 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 150000002367 halogens Chemical class 0.000 claims 12
- 201000002674 obstructive nephropathy Diseases 0.000 claims 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 11
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 9
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 9
- 230000015572 biosynthetic process Effects 0.000 claims 7
- 238000005755 formation reaction Methods 0.000 claims 7
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 7
- 241000124008 Mammalia Species 0.000 claims 6
- 206010038932 Retinopathy Diseases 0.000 claims 6
- 206010038923 Retinopathy Diseases 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 6
- 150000001409 amidines Chemical class 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 6
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 4
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 3
- 206010064930 Age-related macular degeneration Diseases 0.000 claims 3
- 208000000594 Bullous Pemphigoid Diseases 0.000 claims 3
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 3
- 206010015218 Erythema multiforme Diseases 0.000 claims 3
- 208000002780 Macular Degeneration Diseases 0.000 claims 3
- 206010034277 Pemphigoid Diseases 0.000 claims 3
- 206010036590 Premature baby Diseases 0.000 claims 3
- 210000001957 Retinal Vein Anatomy 0.000 claims 3
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- -1 amidino, guanidino, mercapto, sulfo Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 201000004624 dermatitis Diseases 0.000 claims 3
- 231100000406 dermatitis Toxicity 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 230000000302 ischemic Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 230000000414 obstructive Effects 0.000 claims 3
- 230000035699 permeability Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 201000004681 psoriasis Diseases 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 230000004614 tumor growth Effects 0.000 claims 3
- 101710019693 COR6 Proteins 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 230000001575 pathological Effects 0.000 claims 2
- 125000000320 amidine group Chemical group 0.000 claims 1
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40760099A | 1999-09-28 | 1999-09-28 | |
US09/407,600 | 1999-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002111414A true RU2002111414A (en) | 2003-10-27 |
RU2260008C2 RU2260008C2 (en) | 2005-09-10 |
Family
ID=23612752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002111414/04A RU2260008C2 (en) | 1999-09-28 | 2000-09-26 | Substituted pyridines and pyridazines with angiogenesis inhibition activity |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP1228063B1 (en) |
JP (1) | JP4919567B2 (en) |
KR (3) | KR100895571B1 (en) |
CN (3) | CN100374435C (en) |
AR (3) | AR025752A1 (en) |
AT (1) | ATE422494T1 (en) |
AU (1) | AU782820B2 (en) |
BG (1) | BG65860B1 (en) |
BR (1) | BRPI0014382B8 (en) |
CA (1) | CA2385817C (en) |
CO (1) | CO5200835A1 (en) |
CZ (1) | CZ304767B6 (en) |
DE (1) | DE60041548D1 (en) |
DO (1) | DOP2000000070A (en) |
EE (1) | EE05258B1 (en) |
ES (1) | ES2320525T3 (en) |
GT (1) | GT200000158A (en) |
HK (2) | HK1091819A1 (en) |
HR (1) | HRP20020308A2 (en) |
HU (1) | HU230223B1 (en) |
IL (3) | IL148880A0 (en) |
MA (1) | MA25563A1 (en) |
MX (1) | MXPA02003156A (en) |
MY (3) | MY143377A (en) |
NO (1) | NO20021520L (en) |
NZ (1) | NZ518589A (en) |
PA (1) | PA8503201A1 (en) |
PE (1) | PE20010607A1 (en) |
PL (1) | PL205957B1 (en) |
RS (1) | RS50369B (en) |
RU (1) | RU2260008C2 (en) |
SK (1) | SK287417B6 (en) |
TW (1) | TW593315B (en) |
UA (1) | UA75053C2 (en) |
WO (1) | WO2001023375A2 (en) |
ZA (1) | ZA200202760B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL154034A0 (en) * | 2000-08-09 | 2003-07-31 | Astrazeneca Ab | Indole, azaindole and indazole derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
ATE399766T1 (en) | 2000-10-20 | 2008-07-15 | Eisai R&D Man Co Ltd | AROMATIC HETEROCYCLES CONTAINING NITROGEN |
AU2002364102A1 (en) * | 2001-12-21 | 2003-07-30 | Bayer Pharmaceuticals Corporation | Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
TWI299664B (en) | 2003-01-06 | 2008-08-11 | Osi Pharm Inc | (2-carboxamido)(3-amino)thiophene compounds |
CA2518530A1 (en) * | 2003-03-11 | 2004-09-23 | Novartis Ag | Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
US20070082910A1 (en) * | 2003-04-08 | 2007-04-12 | Mitsubishi Pharma Corporation | Specific nad(p)h oxidase inhibitor |
US7683172B2 (en) | 2003-11-11 | 2010-03-23 | Eisai R&D Management Co., Ltd. | Urea derivative and process for preparing the same |
KR100553398B1 (en) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | METHOD OF PREPARING THIENO [3,2-c]PYRIDINE DERIVATIVES AND INTERMEDIATES USED THEREIN |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
WO2006030941A1 (en) | 2004-09-13 | 2006-03-23 | Eisai R & D Management Co., Ltd. | Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor |
KR20070053205A (en) | 2004-09-17 | 2007-05-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Medicinal composition |
EP1925676A4 (en) | 2005-08-02 | 2010-11-10 | Eisai R&D Man Co Ltd | Method for assay on the effect of vascularization inhibitor |
US8304406B2 (en) | 2006-04-15 | 2012-11-06 | Bayer Intellectual Property Gmbh | Compounds for treating pulmonary hypertension |
EP2036557B1 (en) | 2006-05-18 | 2015-10-21 | Eisai R&D Management Co., Ltd. | Antitumor agent for thyroid cancer |
WO2008026748A1 (en) | 2006-08-28 | 2008-03-06 | Eisai R & D Management Co., Ltd. | Antitumor agent for undifferentiated gastric cancer |
US8962655B2 (en) | 2007-01-29 | 2015-02-24 | Eisai R&D Management Co., Ltd. | Composition for treatment of undifferentiated gastric cancer |
AU2008325608B2 (en) | 2007-11-09 | 2013-03-14 | Eisai R & D Management Co., Ltd. | Combination of anti-angiogenic substance and anti-tumor platinum complex |
CN101481380B (en) | 2008-01-08 | 2012-10-17 | 浙江医药股份有限公司新昌制药厂 | Thiofuran pyridazine compound, preparation thereof, pharmaceutical composition and uses thereof |
ES2573515T3 (en) | 2010-06-25 | 2016-06-08 | Eisai R&D Management Co., Ltd. | Anti-tumor agent that uses compounds with combined kinase inhibitory effect |
RU2580609C2 (en) | 2011-04-18 | 2016-04-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Anticancer therapeutic agent |
ES2705950T3 (en) | 2011-06-03 | 2019-03-27 | Eisai R&D Man Co Ltd | Biomarkers to predict and assess the responsiveness of subjects with thyroid and kidney cancer to lenvatinib compounds |
EP2937337A4 (en) | 2012-12-21 | 2016-06-22 | Eisai R&D Man Co Ltd | Amorphous form of quinoline derivative, and method for producing same |
NZ714049A (en) | 2013-05-14 | 2020-05-29 | Eisai R&D Man Co Ltd | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
CN103396361B (en) * | 2013-07-24 | 2016-05-04 | 中国人民解放军第二军医大学 | 3,4-dihydro-isoquinoline anti-tumor compounds and preparation method thereof and application |
TWI721954B (en) | 2014-08-28 | 2021-03-21 | 日商衛材R&D企管股份有限公司 | High-purity quinoline derivative and production method thereof |
RU2017128583A (en) | 2015-02-25 | 2019-03-25 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | METHOD FOR REDUCING THE BITTER OF A QUINOLINE DERIVATIVE |
CA2978226A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharpe & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
CN104804008B (en) * | 2015-03-27 | 2016-03-23 | 亿腾药业(泰州)有限公司 | A kind of method of suitability for industrialized production methylsulfonic acid Telatinib |
AU2016279474B2 (en) | 2015-06-16 | 2021-09-09 | Eisai R&D Management Co., Ltd. | Anticancer agent |
CN107129502B (en) | 2017-04-13 | 2022-08-05 | 泰州亿腾景昂药业股份有限公司 | EOC315Mod.I crystal form compound and preparation method thereof |
CN112830932B (en) * | 2020-12-25 | 2022-04-08 | 泰州亿腾景昂药业股份有限公司 | Free base crystal form of teratinib, preparation method and application thereof |
CA3237696A1 (en) | 2021-11-08 | 2023-05-11 | Progentos Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1453897A (en) * | 1965-06-16 | 1966-07-22 | Thiophene and thienopyridazine derivatives | |
GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
FR1516777A (en) * | 1966-08-02 | 1968-02-05 | Innothera Lab Sa | Thiazole derivatives as well as thiazolo [4,5-d] pyridazine and their preparation |
GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
JPH03106875A (en) * | 1989-09-20 | 1991-05-07 | Morishita Pharmaceut Co Ltd | 1-(3-pyridylmethyl)phthalazine derivative |
ES2224130T3 (en) * | 1994-08-09 | 2005-03-01 | Eisai Co., Ltd. | CONDENSED PIRIDAZINE COMPOUND. |
CO4950519A1 (en) * | 1997-02-13 | 2000-09-01 | Novartis Ag | PHTHALAZINES, PHARMACEUTICAL PREPARATIONS THAT UNDERSTAND THEM AND THE PROCESS FOR THEIR PREPARATION |
ES2342240T3 (en) * | 1998-08-11 | 2010-07-02 | Novartis Ag | ISOQUINOLINE DERIVATIVES WITH ACTIVITY INHIBITED BY ANGIOGENIA. |
BR0009507A (en) * | 1999-03-30 | 2002-01-15 | Novartis Ag | Phthalazine derivatives for the treatment of inflammatory diseases |
AR025068A1 (en) * | 1999-08-10 | 2002-11-06 | Bayer Corp | PIRAZINAS REPLACED AND FUSIONATED PYRIDAZINES, PHARMACEUTICAL COMPOSITION THAT INCLUDE THEM, USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT WITH AN ANGIOGENESIS INHIBITING ACTIVITY |
US6706731B2 (en) * | 2000-02-09 | 2004-03-16 | Novartis Ag | Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
-
2000
- 2000-09-22 AR ARP000104981A patent/AR025752A1/en not_active Application Discontinuation
- 2000-09-22 GT GT200000158A patent/GT200000158A/en unknown
- 2000-09-22 DO DO2000000070A patent/DOP2000000070A/en unknown
- 2000-09-22 CO CO00072226A patent/CO5200835A1/en active IP Right Grant
- 2000-09-25 MY MYPI20051064A patent/MY143377A/en unknown
- 2000-09-25 TW TW089119700A patent/TW593315B/en not_active IP Right Cessation
- 2000-09-25 PE PE2000001004A patent/PE20010607A1/en not_active Application Discontinuation
- 2000-09-25 MY MYPI20051063A patent/MY143580A/en unknown
- 2000-09-25 PA PA20008503201A patent/PA8503201A1/en unknown
- 2000-09-25 MY MYPI20004467A patent/MY135058A/en unknown
- 2000-09-26 HU HU0202704A patent/HU230223B1/en not_active IP Right Cessation
- 2000-09-26 AU AU15696/01A patent/AU782820B2/en not_active Expired
- 2000-09-26 JP JP2001526527A patent/JP4919567B2/en not_active Expired - Lifetime
- 2000-09-26 CN CNB008163693A patent/CN100374435C/en not_active Expired - Lifetime
- 2000-09-26 NZ NZ518589A patent/NZ518589A/en not_active IP Right Cessation
- 2000-09-26 MX MXPA02003156A patent/MXPA02003156A/en active IP Right Grant
- 2000-09-26 WO PCT/US2000/026500 patent/WO2001023375A2/en active Application Filing
- 2000-09-26 KR KR1020087021379A patent/KR100895571B1/en active IP Right Grant
- 2000-09-26 KR KR1020087021380A patent/KR100895572B1/en active IP Right Grant
- 2000-09-26 EE EEP200200161A patent/EE05258B1/en not_active IP Right Cessation
- 2000-09-26 DE DE60041548T patent/DE60041548D1/en not_active Expired - Lifetime
- 2000-09-26 RS YUP-229/02A patent/RS50369B/en unknown
- 2000-09-26 CN CNB2005101271105A patent/CN100422173C/en not_active Expired - Lifetime
- 2000-09-26 CA CA2385817A patent/CA2385817C/en not_active Expired - Lifetime
- 2000-09-26 IL IL14888000A patent/IL148880A0/en active IP Right Grant
- 2000-09-26 ES ES00978215T patent/ES2320525T3/en not_active Expired - Lifetime
- 2000-09-26 RU RU2002111414/04A patent/RU2260008C2/en active
- 2000-09-26 KR KR1020027003972A patent/KR100890473B1/en active IP Right Grant
- 2000-09-26 EP EP00978215A patent/EP1228063B1/en not_active Expired - Lifetime
- 2000-09-26 UA UA2002043504A patent/UA75053C2/en unknown
- 2000-09-26 PL PL366342A patent/PL205957B1/en unknown
- 2000-09-26 SK SK591-2002A patent/SK287417B6/en not_active IP Right Cessation
- 2000-09-26 CN CNB2005101271092A patent/CN100422172C/en not_active Expired - Lifetime
- 2000-09-26 CZ CZ2002-1444A patent/CZ304767B6/en not_active IP Right Cessation
- 2000-09-26 BR BRPI0014382A patent/BRPI0014382B8/en not_active IP Right Cessation
- 2000-09-26 AT AT00978215T patent/ATE422494T1/en not_active IP Right Cessation
-
2002
- 2002-03-26 NO NO20021520A patent/NO20021520L/en unknown
- 2002-04-09 ZA ZA200202760A patent/ZA200202760B/en unknown
- 2002-04-10 HR HR20020308A patent/HRP20020308A2/en not_active IP Right Cessation
- 2002-04-23 BG BG106637A patent/BG65860B1/en unknown
- 2002-04-26 MA MA26619A patent/MA25563A1/en unknown
-
2006
- 2006-11-08 HK HK06112290.6A patent/HK1091819A1/en unknown
- 2006-11-08 HK HK06112289.9A patent/HK1091818A1/en not_active IP Right Cessation
-
2008
- 2008-08-11 IL IL193367A patent/IL193367A/en active IP Right Grant
- 2008-08-11 IL IL193368A patent/IL193368A/en active IP Right Grant
-
2011
- 2011-07-15 AR ARP110102558A patent/AR082231A2/en unknown
- 2011-07-15 AR ARP110102559A patent/AR082232A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002111414A (en) | Substituted pyridines and pyridazines with the ability to inhibit angiogenesis | |
CO5200835A1 (en) | PIRIDINES AND REPLACED PIRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY | |
WO1999032477B1 (en) | Ortho-anthranilamide derivatives as anti-coagulants | |
WO2006046031A8 (en) | Pharmaceutical compounds | |
RU2003132534A (en) | INHIBITORS OF INHIBITING FACTOR OF MIGRATION OF MACROPHAGE AND METHODS OF IDENTIFICATION | |
KR870010030A (en) | Substituted benzamide derivatives, preparation method thereof and pharmaceutical composition containing same | |
ATE123771T1 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE. | |
RU2008100164A (en) | PRODUCTION AND APPLICATION OF COMPOUNDS AS PROTEAZ INHIBITORS | |
DE69120100D1 (en) | Annealed thiophene derivatives, their preparation and use | |
TW200612954A (en) | Anti-angiogenesis methods | |
PT82270B (en) | METHOD FOR PREPARING DERIVATIVES OF 5- (6-IMIDAZO (1,2, -A) PYRIDYL) PYRIDINE | |
PE20020219A1 (en) | 6-PHENYLPYRROLPYRIMIDINDIONE DERIVATIVES AS PHOSPHODIESTERASE 5 INHIBITORS | |
KR930002349A (en) | Triazolopyrimidine derivatives, preparation method thereof and composition comprising the same | |
AR060431A1 (en) | COMPOUNDS FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
JP2003506447A5 (en) | ||
RU2006114746A (en) | PYRIMIDIN-2-AMINE DERIVATIVES AND THEIR APPLICATION AS ANADOSINE RECEPTOR A2B ANTAGONISTS | |
CO5180637A1 (en) | PIRADAZINAS REPLACED AND PIRADAZINAS FUSIONATED WITH INHIBITING ACTIVITY OF ANGIOGENESIS | |
KR880006231A (en) | Imidazolidinone compound and preparation method thereof | |
KR920009810A (en) | Naphthoic acid derivatives | |
RU98119949A (en) | Α-ADRENERGIC RECEPTOR ANTAGONISTS | |
RU96117037A (en) | TRICYCLIC COMPOUNDS CONSISTING TO BRAKING | |
DK43382A (en) | ALKANOLAMINE DERIVATIVES | |
KR910009708A (en) | 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, methods for their preparation and pharmaceutical compositions containing them | |
RU99115082A (en) | DIPHENYLALKYL-TETRAHYDROPYRIDINES, METHOD FOR THEIR RECEPTION AND PHARMACEUTICAL COMPOSITIONS THEM CONTAINING | |
JPWO2020252407A5 (en) |